{"id":11215,"date":"2024-07-08T06:58:29","date_gmt":"2024-07-08T05:58:29","guid":{"rendered":"https:\/\/demo.xltechglobal.com\/mediworld\/betav2\/?p=11215"},"modified":"2024-07-08T06:58:29","modified_gmt":"2024-07-08T05:58:29","slug":"clarivate-and-global-healthcare-intelligence-launch-latam-market-tracking-solution-for-medical-devices","status":"publish","type":"post","link":"https:\/\/demo.xltechglobal.com\/mediworld\/betav2\/clarivate-and-global-healthcare-intelligence-launch-latam-market-tracking-solution-for-medical-devices\/","title":{"rendered":"Clarivate and Global Healthcare Intelligence Launch LatAm Market Tracking Solution for Medical Devices"},"content":{"rendered":"<p>Clarivate Plc, a leading global provider of transformative intelligence, recently released its LatAm market tracking solution, in collaboration with Global Healthcare Intelligence, a leading provider of market intelligence on healthcare infrastructure in frontier markets.<br \/>\nThe new solution is the next phase of an expanding partnership between Clarivate and Global Healthcare Intelligence, enabling in-depth and actionable analysis of the medical device market in Latin America (LatAm).<br \/>\nLeveraging comprehensive datasets and the proprietary Clarivate device catalog for the LatAm region, including Brazil, Colombia, Argentina, Chile, Peru, and Ecuador, clients can analyze over 100 medical devices and 500 product categories.<br \/>\nThe LatAm medical equipment and device markets have seen substantial growth, currently valued at $10 billion annually, with key players Brazil, Mexico, Colombia, Argentina, and Chile accounting for 89% of the regional market, and underscoring LatAm\u2019s pivotal role in the global healthcare industry.1 This surge in market value reflects the increasing demand for cutting-edge medical technologies and the region\u2019s continuous commitment to enhance healthcare infrastructure and accessibility.<br \/>\nAndrew Lee, Vice President Medtech, Life Sciences &#038; Healthcare, Clarivate, said: \u201cAs the LatAm medical device market has observed significant expansion in recent years, there is a growing need for an unbiased source of data that will empower medical equipment and device manufacturers to make informed decisions. In partnership with Global Healthcare Intelligence, LatAm market tracking for Clarivate leverages curated and validated ready-to-access information, quarter after quarter, equipping customers with consistent insight and foresight needed to create innovative treatments, deliver them to patients faster and improve quality of life.\u201d<br \/>\nGuillaume Corpart, Founder and CEO, Global Health Intelligence, said: \u201cLatin America poses unique challenges in regard to accessing reliable market information. We are thrilled to have partnered with Clarivate to deliver this game-changing solution. Medical equipment &#038; Medical device manufacturers are now able to assess market potential and track performance in a consistent and accurate manner across the region\u2019s leading countries.\u201d<br \/>\nThe Clarivate LatAm team of experts support medical device companies and distributors in harnessing the comprehensive real-time data provided by the Clarivate LatAm market tracking solution. From detailed SKU-level data and independent, third-party analysis to share price and market trends, clients can leverage the solution to market their brands more effectively in the region. <\/p>\n","protected":false},"excerpt":{"rendered":"<p>Clarivate Plc, a leading global provider of transformative intelligence, recently released its LatAm market tracking solution, in collaboration with Global Healthcare Intelligence, a leading provider of market intelligence on healthcare infrastructure in frontier markets. The new solution is the next phase of an expanding partnership between Clarivate and Global Healthcare Intelligence, enabling in-depth and actionable [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":11216,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[15],"tags":[],"class_list":["post-11215","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-events"],"acf":[],"_links":{"self":[{"href":"https:\/\/demo.xltechglobal.com\/mediworld\/betav2\/wp-json\/wp\/v2\/posts\/11215","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/demo.xltechglobal.com\/mediworld\/betav2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/demo.xltechglobal.com\/mediworld\/betav2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/demo.xltechglobal.com\/mediworld\/betav2\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/demo.xltechglobal.com\/mediworld\/betav2\/wp-json\/wp\/v2\/comments?post=11215"}],"version-history":[{"count":1,"href":"https:\/\/demo.xltechglobal.com\/mediworld\/betav2\/wp-json\/wp\/v2\/posts\/11215\/revisions"}],"predecessor-version":[{"id":11217,"href":"https:\/\/demo.xltechglobal.com\/mediworld\/betav2\/wp-json\/wp\/v2\/posts\/11215\/revisions\/11217"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/demo.xltechglobal.com\/mediworld\/betav2\/wp-json\/wp\/v2\/media\/11216"}],"wp:attachment":[{"href":"https:\/\/demo.xltechglobal.com\/mediworld\/betav2\/wp-json\/wp\/v2\/media?parent=11215"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/demo.xltechglobal.com\/mediworld\/betav2\/wp-json\/wp\/v2\/categories?post=11215"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/demo.xltechglobal.com\/mediworld\/betav2\/wp-json\/wp\/v2\/tags?post=11215"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}